Pfizer Inc
NYSE: PFE
$26.21
+$0.38 (+1.5%)
Closing Price on November 29, 2024
PFE Articles
CyDex Pharmaceuticals, Inc. has filed to come public via an IPO in what it lists for filing purposes as up to $50 million in securities sales. It has applied to have the common stock approved for...
Published:
Pfizer Inc. (NYSE: PFE) has given some of its basic data points for its analyst meeting today. For starters, the company has reaffirmed its guidance for 2008 that it previously offered. That...
Published:
Last Updated:
These are not the only analyst calls affecting shares of stock this morning, but these are the initial calls that a673b.bigscoots-temp.com is focusing on: AIG (NYSE: AIG) cut to Market Perform at KBW....
Published:
Antigenics Inc. (NASDAQ: AGEN) A study for Cancer vaccine, Oncophage, for the treatment of metastatic melanoma showed mixed results this morning. Shares are down almost 7% to $2.17. The 52 week...
Published:
Icagen Inc. (NASDAQ: ICGN) has announced that it has provided notice to exercise its put option with Pfizer Inc. (NYE: PFE). This is for the private placement of approximately $10 million of Icagen...
Published:
2008 is turning out to be a wacky year. If you are new to trading and investing this is far from the norm. Statistics vary depending on what day of the week it is but this is the worst January...
Published:
Last Updated:
Pfizer Inc. (NYSE: PFE) has posted earnings that are lower than last year’s results, but were actually above analyst expectations from First Call. The drug giant posted $0.52 EPS versus $0.47...
Published:
Last Updated:
Monday is a market holiday in observance of Martin Luther King Day in the U.S. But after that we have an earnings deluge with hundreds of companies issuing their earnings. For the bulk of the...
Published:
Last Updated:
Short interest of stocks listed on the NYSE as of December 31 showed that retailers and financial companies had sharp increases when compared to the figures on December 14. Shares sold short in...
Published:
We are updating our list of tier-one Defensive Stocks since so many of these stocks have run up and since lists need continual updating. Our originally updated list of tier one defensive stocks was...
Published:
Last Updated:
We compiled a list of many companies that just haven’t been able to turn themselves around. On some we offered a road out and on others we feel sorry for the management because getting out of the...
Published:
Last Updated:
The Dogs of the Dow aren’t necessarily the worst performers of the prior year, but they pay the highest the dividend yields. We wanted to review the 10 Dogs of the Dow to see what the outlook and...
Published:
Last Updated:
For the December 14 period, short interest in financial stocks sky-rocketed compared to figures on November 30. Shares sold short in Citigroup (C) grew 20 million to 104.9 million. Shares short in...
Published:
Since it is year-end, we wanted to compile a list of the 2008 likely Dogs of the Dow. We included Friday’s closing prices for each DJIA component and we also gave the current dividend yield. It...
Published:
According to Reuters, Oracle (ORCL) posted strong earnings and offered a robust outlook for its business. Reuters writes that Barclays (BCS) has sued Bear Stearns (BSC) over losses in two hedge funds...
Published: